Market Place
Sourcing Support
Zelluna ASA grants share options in Long-Term Incentive Program
03 Jul 2025 //
GLOBENEWSWIRE
Disclosure of share transfer from Inven2 AS
25 Jun 2025 //
GLOBENEWSWIRE
Zlna New Registered Share Capital
27 May 2025 //
GLOBENEWSWIRE
Disclosure of Shareholding Gjelsten Holding AS
27 May 2025 //
GLOBENEWSWIRE
ZLNA Issuance of Shares Through Set-Off of Option Exercise Fee
24 May 2025 //
GLOBENEWSWIRE
Zelluna ASA: Invitation to Q1 2025 results webcast presentation
30 Apr 2025 //
GLOBENEWSWIRE
Zelluna ASA Annual General Meeting held on April 29, 2025
29 Apr 2025 //
GLOBENEWSWIRE
Zelluna achieves milestone with manufacturing process for ZI-MA4-
22 Apr 2025 //
GLOBENEWSWIRE
Zelluna ASA: Share capital increase registered
27 Mar 2025 //
GLOBENEWSWIRE
Zelluna ASA [ZLNA]: Reverse share split and ISIN change details
27 Mar 2025 //
GLOBENEWSWIRE
Zelluna ASA Becomes First Cell Therapy Firm Listed In Oslo
03 Mar 2025 //
GLOBENEWSWIRE
Ultimovas Announces Business Merger with Zelluna Immunotherapy
17 Dec 2024 //
GLOBENEWSWIRE
Ultimovacs ASA Announces Potential Subsequent Repair Offering
17 Dec 2024 //
GLOBENEWSWIRE
Zelluna collaborates with Lion TCR to develop TCR-NK cell therapies
26 Jun 2020 //
PHARMABIZ
Zelluna collaborates with Lion TCR to develop TCR-NK cell therapies to treat
25 Jun 2020 //
PHARMABIZ
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.